Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 177, Issue 3, Pages 925-934Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2014.09.204
Keywords
Angiogenesis; Endothelial cell; FGF18; Hypertension; MicroRNA
Categories
Funding
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [Hu201188, Hu201084]
- Program for Pu Jiang Scholar at Science and Technology Commission of Shanghai Municipality [11PJ1409000, 13PJ1407800]
- Shanghai Municipal Education Commission and Shanghai Education Development Foundation [13SG42]
- National Natural Science Foundation of China [81273960]
- Funding for Outstanding Junior Faculties at Shanghai Institutions of Higher Learning [ZZszy12048]
- Three-year projects to promote Traditional Chinese Medicine, Shanghai [ZYSNXD-CC-ZDYJ050]
- Key Disciplines of Clinical Integrative Medicine at the State Administration of Traditional Chinese Medicine of China [200903]
Ask authors/readers for more resources
Objectives: MicroRNAs are potent regulators of gene expression and may serve as disease markers. This study aimed to identify the plasma microRNA signature in hypertensive patients, which may help better understand the mechanisms underlying the pathogenesis of hypertension and target organ impairment. Methods and results: Plasma samples from three independent cohorts were analyzed to identify circulating microRNA candidates associated with hypertension in patients. The results revealed that the plasma level of hsa-miR-505, a previously reported tumor suppressive microRNA, was significantly elevated in hypertensive patients. Further studies were carried out in endothelial cells to elucidate the functional significance of the enhanced level of hsa-miR-505. The results showed that hsa-miR-505 expression markedly impaired the migration and tube formation of all three types of endothelial cells examined. Moreover, gene expression analyses and luciferase reporter assay revealed that FGF18, a proangiogenic factor, is a target directly regulated by hsa-miR-505 in endothelial cells, which may in part underlie the function of hsa-miR-505 in angiogenic processes. Conclusions: Our findings indicate that hsa-miR-505 is a novel circulating signature of hypertension, which may play a role in angiogenesis. Our results provide mechanistic insights into hypertension-associated pathogenesis and point hsa-miR-505 as a potential target for intervention of hypertension. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available